Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BioXtreme is an Israeli neurorehabilitation and medical device company developing robotic systems for motor recovery after stroke and other neurological injuries. Its core offering is a rehabilitation robotics platform built around proprietary Error Enhancement technology, which applies adaptive forces during therapy to promote instinctive motor correction and neuromuscular relearning. The company markets deXtreme for upper-limb post-stroke rehabilitation and has also highlighted plaXtreme for fingers and palm rehabilitation. BioXtreme combines robotic hardware, adaptive algorithms, therapy software, and 3D/VR-based training environments for use in rehabilitation settings. The company appears to be a private, active healthcare technology business focused on non-drug rehabilitation solutions rather than therapeutics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Bioxtreme Robotics Rehabilitation.